Navigation Links
Caltech researchers awarded $10M for molecular programming project
Date:8/18/2008

PASADENA, Calif.-- The National Science Foundation's Expeditions in Computing program has awarded $10 million to the Molecular Programming Project, a collaborative effort by researchers at the California Institute of Technology and the University of Washington to establish a fundamental approach to the design of complex molecular and chemical systems based on the principles of computer science.

The focus of their study, molecular programs, are collections of molecules that may perform a computation, fabricate an object, or control a system of molecular sensors and actuators. The project aims to develop tools and theories for molecular programming--such as programming languages and compilers--that will enable systematic design and implementation in the laboratory.

Eventually, molecular programs could be used to manufacture nanoscale objects, to create biochemical circuitry to probe the inner workings of cells, and as "programmable therapies" placed within living cells to diagnose and directly respond to diseases.

"Our project is a response to the fact that the molecular systems people are building today are now so complex, and their behavior so intricate, that future progress hinges on developing the intellectual and practical tools for mastering that complexity, the kinds of tools that computer science has already developed for silicon computers," says Erik Winfree, associate professor of computer science, computation and neural systems, and bioengineering at Caltech, and principal investigator on the project.

"The Molecular Programming Project is one of the 'outputs' from our investment in the Information Science and Technology (IST) initiative over the years," says co-investigator Richard M. Murray, the Thomas E. and Doris Everhart Professor of Control and Dynamical Systems and director of the IST program at Caltech. "The Expeditions program is intended to identify future directions in computing that have the potential
'/>"/>

Contact: Kathy Svitil
ksvitil@caltech.edu
626-395-8022
California Institute of Technology
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. Caltech engineers build mini drug-producing biofactories in yeast
2. Caltech neurobiologists discover individuals who hear movement
3. Caltech scientists awarded $20 million to Power the Planet
4. Caltech researchers find dual-use sexual attraction and population-control chemicals in nematodes
5. UNC, Caltech research finds further evidence for genetic contribution to autism
6. Researchers study facial structures, brain abnormalities to reveal formula for detection of autism
7. Mount Sinai researchers discover technology that silences genes
8. Researchers link cocoa flavanols to improved brain blood flow
9. Researchers create safer alternative to heparin
10. Researchers to study lyme-like illness in Texas
11. UNC researchers find MSG use linked to obesity

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)... The loss of a gene through deletion of genetic m...icant abnormalities in learning and behavior, said... of Medicine ( www.bcm.edu ) in a report that appe... , "This research goes about 95 percent of the w...f individuals to this gene," said Dr. Arthur L. Be...
(Date:11/6/2009)...wire/ -- Auburn Hills, MI-based Law Enforcement In...ts locker system and patent-pending Biometric Acce...t of Health and Human Services, National Institute...er system will support the NIH,s entire police for... medical research agency. The project is expected...
(Date:11/4/2009)...ntists are reluctant to officially endorse green t...es to grow about its protective effects, including...ntion Research , a journal of the American Associa...ction in oral cancer. , Vassiliki Papadimitrako...nt of Thoracic/Head and Neck Medical Oncology at t...
Breaking Biology News(10 mins):Developmental delay could stem from nicotinic receptor deletion 2Does green tea prevent cancer? Evidence continues to brew, but questions remain 2New method may accelerate drug discovery for difficult diseases like Parkinsons 13002 1New method may accelerate drug discovery for difficult diseases like Parkinsons 13002 2New method may accelerate drug discovery for difficult diseases like Parkinsons 13002 3New method may accelerate drug discovery for difficult diseases like Parkinsons 13002 4Full Transcript of Pelosi Press Conference on Health Care Reform 51561 1Full Transcript of Pelosi Press Conference on Health Care Reform 51561 2Full Transcript of Pelosi Press Conference on Health Care Reform 51561 3Full Transcript of Pelosi Press Conference on Health Care Reform 51561 4Full Transcript of Pelosi Press Conference on Health Care Reform 51561 5Full Transcript of Pelosi Press Conference on Health Care Reform 51561 6Full Transcript of Pelosi Press Conference on Health Care Reform 51561 7Full Transcript of Pelosi Press Conference on Health Care Reform 51561 8Full Transcript of Pelosi Press Conference on Health Care Reform 51561 9Full Transcript of Pelosi Press Conference on Health Care Reform 51561 10Full Transcript of Pelosi Press Conference on Health Care Reform 51561 11Full Transcript of Pelosi Press Conference on Health Care Reform 51561 12Full Transcript of Pelosi Press Conference on Health Care Reform 51561 13Full Transcript of Pelosi Press Conference on Health Care Reform 51561 14Full Transcript of Pelosi Press Conference on Health Care Reform 51561 15Full Transcript of Pelosi Press Conference on Health Care Reform 51561 16Full Transcript of Pelosi Press Conference on Health Care Reform 51561 17Full Transcript of Pelosi Press Conference on Health Care Reform 51561 18TriWest Healthcare Alliance Awarded 5 Year 2416 Billion Healthcare Contract 51556 1TriWest Healthcare Alliance Awarded 5 Year 2416 Billion Healthcare Contract 51556 2
...are being slaughtered for their ivory at a pace un... took effect in 1989. But the public outcry that r...ity of Washington conservation biologist contends ...e giant mammals, plight. , The elephant death ra...ent a year based on recent studies, which is actua...
...d - Kiwifruit lovers can look forward to new, nove...ease this week of crucial genetic data which fruit...arieties with increased health properties and exci...ealand-based fruit science company HortResearch an...rch and Development Corporation Limited announced ...
...d a drug to achieve normal levels of blood sugar i...y high insulin levels. If this approach succeeds i...or children with congenital hyperinsulinism, a rar...hich insulin levels become dangerously high. , "T...or children with the most common type of congenita...
Other Biology News:Ivory poaching at critical levels: Elephants on path to extinction by 2020? 2Ivory poaching at critical levels: Elephants on path to extinction by 2020? 3Genetic data promises new future for kiwi fruit 2Genetic data promises new future for kiwi fruit 3Treatment corrects severe insulin imbalance in animal studies 2Treatment corrects severe insulin imbalance in animal studies 3
(Date:11/6/2009)...D, Calif., Nov. 6 Intarcia Therape...ts ITCA 650 (DUROS® continuous delivery of ex...tes at the Ninth Annual Diabetes Technology Meetin...ewscom.com/cgi-bin/prnh/20050301/SFTU126LOGO ) ,... Via ITCA 650 Lowers Plasma Glucose, HbA1c and Red...
(Date:11/5/2009)...RSBURG, Md., Nov. 5 GenV...ncial results for the third quarter ended Septembe...lion ($0.04 per share) for the three months ended ...million ($0.08 per share) in the comparable quarte... 2009, GenVec,s net loss was $14.1 million ($0.15 ...
(Date:11/5/2009)...EGO, Nov. 5 Imagenetix, ...hat William Spencer, President and CEO of Imagenet...2nd annual LD MICRO Conference on Thursday, Decemb...Angeles. ,, About LD MICRO ,, LD MICRO is a ... finding undervalued companies in the micro-cap sp...
(Date:11/5/2009)... Neb., Nov. 5 Transgenom...d financial results for the quarter ended Septembe...esented in the tables that follow. ,, Third Qu...of $366,000 or $0.01 per share for the third quart...r $0.01 per share for the third quarter of 2008. ...
Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7
...ALTHAM, Mass., Aug. 18 Logical Therapeutics, Inc....nt of medicines that treat,diseases associated wit...the successful completion of its Phase 1b randomiz...cs study of LT-NS001, the Company,s proprietary,na...m December, 2007,through July, 2008 in normal adul...
...AN DIEGO, Aug. 18 LifeVantage Corporation,(OTC Bu...e only product,clinically proven to slow the progr...pany,s President & CEO, David Brown, is featured i...Press Show., The interview gives viewers an overv...mpany,s latest press release., To view the cli...
...HILADELPHIA, Aug. 17 /Xinhua-PRNewswire/ -- WuXi A...ech (NYSE: WX ) in the U.S., has announced,the ap... of Operations and,Joseph Hughes, Ph.D. as Vice Pr...acility., (Logo: http://www.newscom.com/cgi-bin/...ith the company for nine years in roles of,increas...
Other Biology Technology:Logical Therapeutics Inc. Announces Results of Phase 1b Clinical Study of its Naproxen Prodrug 2[video] David Brown, President and CEO of LifeVantage Corporation, Discusses Record Page Views on WallSt.net's 3-Minute Press Show 2WuXi AppTec Appoints Garry Takle, Ph.D. as VP of Operations and Joseph Hughes, Ph.D. as VP of Testing Services for Philadelphia Facility 2
Smarter Fermentation System Controller for One Vessel from Major Science
...are specifically depleted of a single complement p..., the alternative and classical pathways are left ... detection and quantitation of hemolytically activ...used to assess complement activation in non-human ...
Dispensing Bins from Terra Universal, Inc.
Midgard Prec Current Source from Stoelting Co.
Biology Products: